Mechanisms of irregular bleeding with hormone therapy: The role of matrix metalloproteinases and their tissue inhibitors

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 8, 2006, Pages 3189-3198

  Hickey, M ^a,d   Crewe, J ^a   Mahoney, L A ^a   Doherty, D A ^a   Fraser, I S ^b   Salamonsen, L A ^c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d KING EDWARD MEMORIAL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; GELATINASE B; GESTAGEN; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE INHIBITOR; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ADULT; AMENORRHEA; ARTICLE; AUSTRALIA; BLEEDING; CONTROLLED STUDY; ENDOMETRIUM; FEMALE; HISTOPATHOLOGIC SKIN REACTION; HORMONAL THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; POSTMENOPAUSE; PRIORITY JOURNAL; TERTIARY HEALTH CARE;

EID: 33747712589     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-2748     Document Type: Article

References (45)

1. MacLennan A, Lester S, Moore V 2001 Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review. Climacteric 4:58-74
2. Christodoulakos GE, Botsis DS, Lambrinoudaki IV, Papagianni VD, Panoulis CP, Creatsa MG, Alexandrou AP, Augoulea AD, Dendrinos SG, Creatsas GC 2006 A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness. Maturitas 53:413-423
3. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333
4. Ettinger B, Li DK, Klein R 1998 Unexpected vaginal bleeding and associated gynecologic care in postmenopausal women using hormone replacement therapy: comparison of cyclic versus continuous combined schedules. Fertil Steril 69:865-869
5. Elliott J, Connor ME, Lashen H 2003 The value of outpatient hysteroscopy in diagnosing endometrial pathology in postmenopausal women with and without hormone replacement therapy. Acta Obstet Gynecol Scand 82:1112-1119
6. Thomas AM, Hickey M, Fraser IS 2000 Disturbances of endometrial bleeding with hormone replacement therapy. Hum Reprod 15(Suppl 3):7-17
7. Hickey M, Pillai G, Higham JM, Sullivan M, Horncastle D, Doherty D, Stamp G 2003 Changes in endometrial blood vessels in the endometrium of women with hormone replacement therapy-related irregular bleeding. Hum Reprod 18:1100-1106
8. Wells M, Sturdee DW, Barlow DH, Ulrich LG, O'Brien K, Campbell MJ, Vessey MP, Bragg AJ 2002 Effect on endometrium of long term treatment with continuous combined estrogen/progestogen replacement therapy: follow up study. BMJ 325:239-242
9. Hickey M, Higham J, Sullivan M, Miles L, Fraser IS 2001 Endometrial bleeding in hormone replacement therapy users: preliminary findings regarding the role of matrix metalloproteinase 9 (MMP-9) and tissue inhibitors of MMPs. Fertil Steril 75:288-296
10. Hickey M, Crewe J, Goodridge JP, Witt CS, Fraser IS, Doherty D, Christiansen FT, Salamonsen LA 2005 Menopausal hormone therapy and irregular endometrial bleeding: a potential role for uterine natural killer cells? J Clin Endocrinol Metab 90:5528-5535
11. Salamonsen LA, Lathbury LJ 2000 Endometrial leukocytes and menstruation. Hum Reprod Update 6:16-27
12. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA 1993 Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4:197-250
13. Vassilev V, Pretto CM, Cornet PB, Delvaux D, Eeckhout Y, Courtoy PJ, Marbaix E, Henriet P 2005 Response of matrix metalloproteinases and tissue inhibitors of metalloproteinases messenger ribonucleic acids to ovarian steroids in human endometrial explants mimics their gene- and phase-specific differential control in vivo. J Clin Endocrinol Metab 90:5848-5857
14. Zhang J, Hampton AL, Nie G, Salamonsen LA 2000 Progesterone inhibits activation of latent matrix metalloproteinase (MMP)-2 by membrane-type 1 MMP: enzymes coordinately expressed in human endometrium. Biol Reprod 62:85-94
15. Zhang J, Salamonsen LA 2002 In vivo evidence for active matrix metalloproteinases in human endometrium supports their role in tissue breakdown at menstruation. J Clin Endocrinol Metab 87:2346-2351
16. Skinner JL, Riley SC, Gebbie AE, Glasier AF, Critchley HO 1999 Regulation of matrix metalloproteinase-9 in endometrium during the menstrual cycle and following administration of intrauterine levonorgestrel. Hum Reprod 14:793-799
17. Marbaix E, Vekemans M, Galant C, Rigot V, Lemoine P, Dubois D, Picquet C, Henriet P, Twagirayezu P, Sufi S, Eeckhout Y, Courtoy PJ 2000 Circulating sex hormones and endometrial stromelysin-1 (matrix metalloproteinase-3) at the start of bleeding episodes in levonorgestrel-implant users. Hum Reprod 15(Suppl 3):120-134
18. Vincent AJ, Zhang J, Ostor A, Rogers PA, Affandi B, Kovacs G, Salamonsen LA 2002 Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: a role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uterine bleeding? Hum Reprod 17:1189-1198
19. Song JY, Russell P, Markham R, Manconi F, Fraser IS 1996 Effects of high dose progestogens on white cells and necrosis in human endometrium. Hum Reprod 11:1713-1718
20. Vincent AJ, Salamonsen LA 2000 The role of matrix metalloproteinases and leukocytes in abnormal uterine bleeding associated with progestin-only contraceptives. Hum Reprod 15(Suppl 3):135-143
21. Belsey EM 1991 Menstrual bleeding patterns in untreated women and with long-acting methods of contraception. Task Force on Long-Acting Systemic Agents for Fertility Regulation. Adv Contracept 7:257-270
22. Noyes RW, Hertig AT, Rock J 1975 Dating the endometrial biopsy. Am J Obstet Gynecol 122:262-263
23. Burton P, Gurrin L, Sly P 1998 Extending the simple linear regression model to account for correlated responses: an introduction to generalized estimating equations and multi-level mixed modelling. Stat Med 17:1261-1291
24. Galant C, Vekemans M, Lemoine P, Kokorine I, Twagirayezu P, Henriet P, Picquet C, Rigot V, Eeckhout Y, Courtoy PJ, Marbaix E 2000 Temporal and spatial association of matrix metalloproteinases with focal endometrial breakdown and bleeding upon progestin-only contraception. J Clin Endocrinol Metab 85:4827-4834
25. Galant C, Berliere M, Dubois D, Verougstraete JC, Charles A, Lemoine P, Kokorine I, Eeckhout Y, Courtoy PJ, Marbaix E 2004 Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endometrial bleeding. Am J Pathol 165:83-94
26. Sato T, Koike L, Miyata Y, Hirata M, Mimaki Y, Sashida Y, Yano M, Ito A 2002 Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix metalloproteinases-1 and -9 in human fibrosarcoma HT-1080 cells. Cancer Res 62:1025-1029
27. Sohara N, Trojanowska M, Reuben A 2002 Oncostatin M stimulates tissue inhibitor of metalloproteinase-1 via a MEK-sensitive mechanism in human myofibroblasts. J Hepatol 36:191-199
28. Hickey M, Higham JM, Fraser IS 2001 Hormone replacement therapy and irregular bleeding. Climacteric 4:95-101
29. Lambert E, Dasse E, Haye B, Petitfrere E 2004 TIMPs as multifacial proteins. Crit Rev Oncol Hematol 49:187-198
30. Pilka R, Domanski H, Hansson S, Eriksson P, Casslen B 2004 Endometrial TIMP-4 mRNA is high at midcycle and in hyperplasia, but down-regulated in malignant tumours. Coordinated expression with MMP-26. Mol Hum Reprod 10:641-650
31. Chegini N, Rhoton-Vlasak A, Williams RS 2003 Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleeding. Fertil Steril 80:564-570
32. Murphy AN, Unsworth EJ, Stetler-Stevenson WG 1993 Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol 157:351-358
33. Wahab M, Thompson J, Al-Azzawi F 2000 Effect of different cyclical sequential progestins on endometrial vascularity in postmenopausal women compared with the natural cycle: a morphometric analysis. Hum Reprod 15:2075-2081
34. Lockwood CJ, Schatz F, Krikun G 2004 Angiogenic factors and the endometrium following long term progestin only contraception. Histol Histopathol 19:167-172
35. Salamonsen LA, Zhang J, Hampton A, Lathbury L 2000 Regulation of matrix metalloproteinases in human endometrium. Hum Reprod 15(Suppl 3):112-119
36. Weisberg E, Hickey M, Palmer D, O'Connor V, Salamonsen LA, Findlay JK, Fraser IS 2006 A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon. Hum Reprod 21:295-302
37. Salamonsen LA, Zhang J, Brasted M 2002 Leukocyte networks and human endometrial remodelling. J Reprod Immunol 57:95-108
38. Ferenczy A 2003 Pathophysiology of endometrial bleeding. Maturitas 45:1-14
39. Lacraz S, Nicod LP, Chicheportiche R, Welgus HG, Dayer JM 1995 IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 96:2304-2310
40. Stetler-Stevenson M, Mansoor A, Lim M, Fukushima P, Kehrl J, Marti G, Ptaszynski K, Wang J, Stetler-Stevenson WG 1997 Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells. Blood 89:1708-1715
41. Albertsson P, Kim MH, Jonges LE, Kitson RP, Kuppen PJ, Johansson BR, Nannmark U, Goldfarb RH 2000 Matrix metalloproteinases of human NK cells. In Vivo 14:269-276
42. Faundes A, Alvarez-Sanchez F, Brache V, Jimenez E, Tejada AS 1991 Hormonal changes associated with bleeding during low dose progestogen contraception delivered by Norplant subdermal implants. Adv Contracept 7:85-94
43. Ettinger B 2005 Vasomotor symptom relief versus unwanted effects: role of estrogen dosage. Am J Med 118:74-78
44. Elsandabesee D, Greenwood P 2005 The performance of Pipelle endometrial sampling in a dedicated postmenopausal bleeding clinic. J Obstet Gynaecol 25:32-34
45. Lockwood CJ, Runic R, Wan L, Krikun G, Demopolous R, Schatz F 2000 The role of tissue factor in regulating endometrial haemostasis: implications for progestin-only contraception. Hum Reprod 15(Suppl 3):144-151